OPPM
Opus Point Partners Management Portfolio holdings
AUM
$46.9M
This Quarter Return
+9.12%
1 Year Return
-4.17%
3 Year Return
+83.22%
5 Year Return
+175.29%
10 Year Return
–
AUM
$102M
AUM Growth
+$102M
(+14%)
Cap. Flow
+$4.77M
Cap. Flow
% of AUM
4.69%
Top 10 Holdings %
Top 10 Hldgs %
47.07%
Holding
64
New
3
Increased
23
Reduced
5
Closed
4
Top Buys
| 1 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
$631K |
| 2 |
Acadia Pharmaceuticals
ACAD
|
$589K |
| 3 |
United Therapeutics
UTHR
|
$481K |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$336K |
| 5 |
Ultragenyx Pharmaceutical
RARE
|
$306K |
Top Sells
| 1 |
KITE
Kite Pharma, Inc.
KITE
|
$613K |
| 2 |
Myriad Genetics
MYGN
|
$527K |
| 3 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
$404K |
| 4 |
Iovance Biotherapeutics
IOVA
|
$220K |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$192K |
Sector Composition
| 1 | Healthcare | 78.98% |
| 2 | Real Estate | 0.38% |
